Article Information
History
- May 7, 2022.
Article Versions
- You are currently viewing Version 1 of this article (May 7, 2022 - 09:19).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Franziska Knolle1,2,*,
- Shyam S. Arumugham3,
- Roger A. Barker4,
- Michael W.L. Chee5,6,
- Azucena Justicia2,7,
- Nitish Kamble8,
- Jimmy Lee9,10,11,
- Siwei Liu5,6,
- Abhishek Lenka8,12,
- Simon J.G. Lewis13,
- Graham K. Murray2,14,
- Pramod Kumar Pal8,
- Jitender Saini8,
- Jennifer Szeto13,
- Ravi Yadav3,
- Juan H. Zhou5,6 and
- Kathrin Koch1,*
- 1Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Technical University of Munich, Munich, Germany
- 2Department of Psychiatry, University of Cambridge, Cambridge UK
- 3Department of Psychiatry, National Institute of Mental Health & Neurosciences (NIMHANS), Bengaluru, India
- 4Department of Clinical Neuroscience, University of Cambridge, Cambridge, UK
- 5Centre for Sleep and Cognition, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
- 6Centre for Translational MR Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
- 7IMIM (Hospital del Mar Medical Research Institute), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain
- 8Department of Neurology, National Institute of Mental Health & Neurosciences (NIMHANS), Bengaluru, India
- 9Research Division, Institute of Mental Health, Singapore
- 10Department of Psychosis, Institute of Mental Health, Singapore
- 11Neuroscience and Mental Health, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
- 12Department of Neurology, Medstar Georgetown University School of Medicine, Washington, DC, USA
- 13ForeFront Parkinson’s Disease Research Clinic, Brain and Mind Centre, School of Medical Sciences, University of Sydney, Camperdown, NSW, Australia
- 14Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK
- ↵*Corresponding authors: Dr. Franziska Knolle Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University Munich, 81675 Munich, Germany Phone: +49 89 4041 7976 Fax: +49 89 4140 4653 Email: franziska.knolle{at}tum.de Dr. Kathrin Koch Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University Munich, 81675 Munich, Germany Phone: +49 89 4041 7972 Fax: +49 89 4140 4653 Email: kathrin.koch{at}tum.de
Posted May 07, 2022.
Grey matter morphometric biomarkers for classifying early schizophrenia and PD psychosis: a multicentre study
